Astria Therapeutics (NASDAQ:ATXS) just reported results for the second quarter of 2024.
- Astria Therapeutics reported earnings per share of -43 cents. This was below the analyst estimate for EPS of -38 cents.
- The company did not report any revenue for the quarter.